Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats: Impact on therapeutics.

Saudi medical journal2021Alshabi AM, Alkahtani SA, Shaikh IA, et al.

Study designOther primary literature

SubjectHuman & animal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsCaffeineDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2HumansHypoglycemic AgentsPioglitazoneRatsRats, WistarSaudi ArabiaThiazolidinediones

DOI 10.15537/smj.2021.2.25695

PMID 33563733

View source →